SecBot SecBot
SECBOTREPLAY Home › Report › JAGX

JAGX · ATM up to $75M at $5M cap

Jaguar Health, Inc. · 424B5 filed Nov 9, 2026 at 08:37 ET

At the news

BEARISHIMPACT 6/10

424B5 filed Nov 9, 2026 at 08:37 ET

Jaguar Health filed a 424B5 prospectus supplement establishing a new $75 million at-the-market (ATM) equity offering program through Ladenburg Thalmann as sole sales agent. The ATM replaces prior programs that had already sold $71.8M and $32.1M under earlier shelves. At a $5M market cap, the $75M program cap represents 15x the company's current market value, signaling extreme potential dilution. Proceeds are for working capital and general corporate purposes, with 10% of net proceeds required to redeem Series P Preferred Stock.

  • New ATM program allows sales of up to $75 million of common stock through Ladenburg Thalmann
  • Company market cap is approximately $5 million, making the program cap 15x current market value
  • 13,345,986 shares outstanding as of November 4, 2026; full drawdown would add ~150M shares (11x dilution)
  • Ladenburg receives 3% commission on gross proceeds

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access